Dr. Edward Miller, MD
Claim this profileYale-New Haven Hospital
Studies Cardiomyopathy
Studies Heart Failure
3 reported clinical trials
5 drugs studied
Area of expertise
1Cardiomyopathy
wild-type ATTR negative
V142I ATTR mutation positive
2Heart Failure
wild-type ATTR negative
V142I ATTR mutation positive
Affiliated Hospitals
Clinical Trials Edward Miller, MD is currently running
18F-Flutemetamol PET Imaging
for Cardiomyopathy
18F-Flutemetamol (Vizamyl) is a radioactive diagnostic agent indicated and FDA-approved for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) or other causes of cognitive decline. This study is designed to evaluate a novel use for 18F-Flutemetamol in cardiac amyloidosis.
Recruiting1 award Phase 16 criteria
Prednisone/Prednisolone Dosing
for Cardiac Sarcoidosis
Prospective randomized controlled trial comparing low dose Prednisone(or Prednisolone)/Methotrexate combination to standard dose Prednisone(or Prednisolone) in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone(or Prednisolone)/Methotrexate combination will be as effective as standard dose Prednisone(or Prednisolone), and result in significantly better quality of life and less toxicity than standard dose Prednisone(or Prednisolone).
Recruiting4 awards Phase 35 criteria
More about Edward Miller, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Edward Miller, MD has experience with
- (18F)Flutemetamol
- ATTR Diagnostic Algorithm
- Methotrexate
- Prednisone
- Prednisone Or Prednisolone
Breakdown of trials Edward Miller, MD has run
Cardiomyopathy
Heart Failure
Amyloidosis
Cardiac Sarcoidosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edward Miller, MD specialize in?
Edward Miller, MD focuses on Cardiomyopathy and Heart Failure. In particular, much of their work with Cardiomyopathy has involved wild-type ATTR negative patients, or patients who are V142I ATTR mutation positive.
Is Edward Miller, MD currently recruiting for clinical trials?
Yes, Edward Miller, MD is currently recruiting for 3 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Edward Miller, MD has studied deeply?
Yes, Edward Miller, MD has studied treatments such as (18F)Flutemetamol, ATTR diagnostic algorithm, Methotrexate.
What is the best way to schedule an appointment with Edward Miller, MD?
Apply for one of the trials that Edward Miller, MD is conducting.
What is the office address of Edward Miller, MD?
The office of Edward Miller, MD is located at: Yale-New Haven Hospital, New Haven, Connecticut 06520 United States. This is the address for their practice at the Yale-New Haven Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.